Breaking News Instant updates and real-time market news.

CRAI

CRA International

$47.76 /

-2.24 (-4.48%)

08:33
02/27/20
02/27
08:33
02/27/20
08:33

CRA International announces CFO Chad Holmes to transition to new role

Charles River Associates announced plans to divide the responsibilities of its CFO and chief corporate development officer into two executive officer positions reporting directly to Paul Maleh, president and CEO. The plan to separate these positions comes as CRA continues to develop its corporate infrastructure in support of its ongoing growth and success. Chad Holmes, who has been CFO since 2014 and has led CRA's corporate development efforts since 2009, will transition to the new role of executive VP and chief corporate development officer. In this position, Holmes will focus full-time on CRA's capital allocation and deployment, including a continued emphasis on corporate development activities. Holmes will be responsible for adding to the breadth, depth and scale of CRA's consulting capabilities through prudent capital allocation and deployment, which may include pursuing individual and group hires, acquisitions or organic growth initiatives. Holmes will continue to serve as CFO until a successor has transitioned into the role. CRA has initiated a search for its next CFO.

  • 27

    Feb

  • 26

    Mar

CRAI CRA International
$47.76 /

-2.24 (-4.48%)

01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
11/01/19 Barrington
CRA International price target raised to $59 from $53 at Barrington
07/24/19 Barrington
CRA International initiated with an Outperform at Barrington

TODAY'S FREE FLY STORIES

Upgrade
First Republic upgraded to Buy from Neutral at BofA » 06:30
04/01/20
04/01
06:30
04/01/20
06:30
FRC

First Republic

$82.28 /

-4.31 (-4.98%)

BofA analyst Erika…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
UDR downgraded to Underweight from Equal Weight at Morgan Stanley » 06:28
04/01/20
04/01
06:28
04/01/20
06:28
UDR

UDR

$36.55 /

-1.1 (-2.92%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Essex Property Trust downgraded to Equal Weight from Overweight at Morgan Stanley » 06:28
04/01/20
04/01
06:28
04/01/20
06:28
ESS

Essex Property Trust

$220.14 /

-4.97 (-2.21%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Incyte upgraded to Overweight from Equal Weight at Morgan Stanley » 06:28
04/01/20
04/01
06:28
04/01/20
06:28
INCY

Incyte

$73.13 /

+0.96 (+1.33%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Amarin price target lowered to $6 from $24 at Citi » 06:28
04/01/20
04/01
06:28
04/01/20
06:28
AMRN

Amarin

$3.99 /

-9.6 (-70.64%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Macau reports March casino revenue down 79.7% to 5.257B patacas » 06:27
04/01/20
04/01
06:27
04/01/20
06:27
LVS

Las Vegas Sands

$42.32 /

-1.17 (-2.69%)

, MGM

MGM Resorts

$11.80 /

+0.26 (+2.25%)

, WYNN

Wynn Resorts

$60.02 /

-1.07 (-1.75%)

, MLCO

Melco Resorts & Entertainment

$12.41 /

-0.085 (-0.68%)

Macau's gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Dollar Tree upgraded to Buy from Neutral at Citi » 06:26
04/01/20
04/01
06:26
04/01/20
06:26
DLTR

Dollar Tree

$73.48 /

-6.33 (-7.93%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Trane downgraded to Neutral from Buy at BofA » 06:26
04/01/20
04/01
06:26
04/01/20
06:26
TT

Trane

$82.52 /

-1.33 (-1.59%)

BofA analyst Andrew Obin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
D.R. Horton upgraded to Outperform from Neutral at Wedbush » 06:25
04/01/20
04/01
06:25
04/01/20
06:25
DHI

D.R. Horton

$34.00 /

-2.91 (-7.88%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
HD Supply downgraded to Neutral from Buy at Longbow » 06:25
04/01/20
04/01
06:25
04/01/20
06:25
HDS

HD Supply

$28.45 /

+0.81 (+2.93%)

Longbow analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Dollar General assumed with a Buy at Citi » 06:24
04/01/20
04/01
06:24
04/01/20
06:24
DG

Dollar General

$151.27 /

+4.66 (+3.18%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Akorn says 'no longer has any bids that are sufficient to pay all obligations' » 06:24
04/01/20
04/01
06:24
04/01/20
06:24
AKRX

Akorn

$0.56 /

-0.0849 (-13.16%)

Akorn, announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Astec upgraded to Outperform from Neutral at Baird » 06:24
04/01/20
04/01
06:24
04/01/20
06:24
ASTE

Astec

$34.84 /

+2.38 (+7.33%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
KKR postpones plan to sell Goodpack amid COVID-19 pandemic, Reuters reports » 06:23
04/01/20
04/01
06:23
04/01/20
06:23
KKR

KKR

$23.50 /

-1.02 (-4.16%)

KKR has put off a plan to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Dollar Tree downgraded to Market Perform from Outperform at Telsey Advisory » 06:23
04/01/20
04/01
06:23
04/01/20
06:23
DLTR

Dollar Tree

$73.48 /

-6.33 (-7.93%)

Telsey Advisory analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Eidos Therapeutics resumed with a Neutral at BofA » 06:22
04/01/20
04/01
06:22
04/01/20
06:22
EIDX

Eidos Therapeutics

$48.86 /

-0.04 (-0.08%)

BofA analyst Geoff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
TSMC on track to move 5nm technology to volume production in Q2, DigiTimes says » 06:22
04/01/20
04/01
06:22
04/01/20
06:22
TSM

TSMC

$47.79 /

-0.04 (-0.08%)

, AAPL

Apple

$254.28 /

-0.61 (-0.24%)

TSMC (TSM) is on track to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Denny's upgraded to Buy from Hold at SunTrust » 06:21
04/01/20
04/01
06:21
04/01/20
06:21
DENN

Denny's

$7.68 /

-0.17 (-2.17%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
SoftBank-backed Oyo furloughs most of its U.K. staff, Yahoo Finance reports » 06:20
04/01/20
04/01
06:20
04/01/20
06:20
SFTBF

Use SFTBY

$0.00 /

+ (+0.00%)

, SFTBY

SoftBank

$0.00 /

+ (+0.00%)

SoftBank-backed hotel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
El Pollo Loco upgraded to Buy from Hold at SunTrust » 06:20
04/01/20
04/01
06:20
04/01/20
06:20
LOCO

El Pollo Loco

$8.46 /

+0.46 (+5.75%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
BioXcel Therapeutics initiated with a Buy at BofA » 06:19
04/01/20
04/01
06:19
04/01/20
06:19
BTAI

BioXcel Therapeutics

$22.40 /

-1.96 (-8.05%)

BofA analyst Geoff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Kansas City Southern downgraded to Neutral from Buy at UBS » 06:19
04/01/20
04/01
06:19
04/01/20
06:19
KSU

Kansas City Southern

$127.15 /

-2.11 (-1.63%)

UBS analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Epizyme downgraded to Perform from Outperform at Oppenheimer » 06:18
04/01/20
04/01
06:18
04/01/20
06:18
EPZM

Epizyme

$15.41 /

-1.12 (-6.78%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
ShockWave Medical downgraded to Underperform from Perform at Oppenheimer » 06:17
04/01/20
04/01
06:17
04/01/20
06:17
SWAV

ShockWave Medical

$33.11 /

-2.86 (-7.95%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Crispr Therapeutics study halts not unexpected, says Piper Sandler » 06:17
04/01/20
04/01
06:17
04/01/20
06:17
CRSP

Crispr Therapeutics

$42.26 /

-2.08 (-4.69%)

Crispr Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.